Trilostane (Vetoryl) for Dogs: Cushing’s Disease, Monitoring, Side Effects & Safety

Trilostane is a prescription medicine used to control excessive cortisol production in dogs with Cushing’s disease (hyperadrenocorticism). In the United States, Vetoryl (trilostane) is FDA-approved for both pituitary-dependent and adrenal-dependent Cushing’s disease. It is one of the most important long-term medicines in canine endocrinology, but it is not a medicine that can be safely managed by symptoms alone.

Trilostane works by inhibiting an adrenal enzyme involved in steroid-hormone production. That can reduce the excessive cortisol responsible for signs such as increased thirst, increased urination, excessive appetite, panting, muscle weakness, a pot-bellied appearance and recurrent skin problems. The therapeutic challenge is to suppress cortisol enough to improve disease without suppressing adrenal function too far.

Why dogs with Cushing’s may receive trilostane

Most canine Cushing’s cases are caused by a pituitary tumor that drives both adrenal glands to produce too much cortisol. A smaller proportion are caused by an adrenal tumor. Trilostane acts at the adrenal gland, so it can be used in both forms even though the disease starts in different places.

Diagnosis should come before treatment. Older dogs can have increased thirst, hair thinning, liver-enzyme changes or a pot-bellied shape for reasons other than Cushing’s disease. Veterinarians combine clinical signs with endocrine testing and, when needed, imaging before committing a dog to long-term adrenal suppression.

What trilostane actually changes

Trilostane inhibits 3-beta-hydroxysteroid dehydrogenase, an enzyme involved in cortisol and other adrenal steroid synthesis. It does not remove a pituitary or adrenal tumor. Instead, it controls the hormone excess produced downstream.

That distinction explains why treatment is usually long term. If signs improve, it generally means cortisol production is being controlled; it does not mean the underlying endocrine disease has disappeared.

What improvement can look like

Owners often first notice a reduction in excessive thirst and urination, less frantic appetite, less panting or improved energy. Skin and coat changes usually take longer because hair growth and resolution of chronic skin disease occur slowly.

The goal is not to make the dog quiet, weak or uninterested in food. Marked appetite loss, vomiting, diarrhea, profound lethargy or collapse can mean adrenal suppression has gone too far and should trigger veterinary contact.

Why monitoring is essential

FDA emphasizes that dogs receiving trilostane need regular veterinary checkups and blood testing, particularly during the first months and after dose changes. Monitoring commonly combines the owner’s report of clinical signs with blood chemistry, electrolytes and adrenal-function testing selected by the veterinarian.

There is no single home sign that proves the dose is correct. A dog may drink less because treatment is working, but reduced drinking combined with vomiting and weakness can signal hypoadrenocorticism. Trends must be interpreted in context.

Trilostane can cause too little adrenal hormone

The most important serious risk is iatrogenic hypoadrenocorticism—essentially creating an Addisonian state by suppressing adrenal steroid production too strongly. Dogs may develop poor appetite, vomiting, diarrhea, weakness, dehydration, abnormal sodium and potassium, or collapse.

Most medication-related suppression can improve after trilostane is stopped and supportive treatment is given, but rare adrenal necrosis can produce permanent adrenal insufficiency. That is why owners should not wait several days when a treated dog suddenly becomes very ill.

When to stop and call the veterinarian

FDA owner information for Vetoryl advises owners to stop the medicine and contact the veterinarian if the dog becomes ill. Important warning signs include vomiting, diarrhea, loss of appetite, weakness, severe lethargy or collapse.

Do not restart after a significant illness simply because the dog seems better the next morning. The veterinary team may want electrolytes, kidney values or adrenal testing before deciding when and how treatment resumes.

Giving trilostane with food

Vetoryl labeling instructs that the medicine be given with food. Food improves absorption and makes exposure more predictable. Consistency matters because changing from routinely giving it with a meal to routinely giving it on an empty stomach can change how much drug is absorbed.

If the dog refuses food, that is not merely an administration inconvenience. Appetite loss is also a potential warning sign of excessive adrenal suppression, so contact the clinic rather than hiding the capsule in a large number of treats and hoping the dog eats.

Why the exact product and strength matter

Trilostane is available in multiple capsule strengths. The veterinary prescription is chosen around the dog’s condition and response, and capsules should not be casually opened or divided to improvise a different strength. Handle the prescribed product according to its label.

At every refill, confirm the capsule strength and directions. If the appearance or instructions change, verify the prescription before dosing.

Pituitary-dependent versus adrenal-dependent disease

Pituitary-dependent Cushing’s is usually driven by excessive ACTH from a pituitary tumor, stimulating both adrenal glands. Adrenal-dependent disease originates in an adrenal tumor that produces cortisol more autonomously.

Trilostane can control cortisol in either situation, but the long-term plan differs. An adrenal tumor may be evaluated for surgery; a large pituitary tumor can cause neurologic problems not corrected by cortisol control alone. Treatment is therefore more than choosing a capsule.

Trilostane versus mitotane

Mitotane is an older adrenolytic drug that destroys cortisol-producing adrenal tissue. Trilostane inhibits steroid synthesis rather than deliberately destroying adrenal tissue. The two medicines therefore have different mechanisms and monitoring approaches.

Merck identifies trilostane as the treatment of choice for most dogs with hyperadrenocorticism, while mitotane may still have a role in selected cases such as some dogs with calcinosis cutis or atypical disease. A switch should be planned by a veterinarian experienced in endocrine treatment.

What if a dose is missed?

Do not double the next dose unless the prescribing veterinarian specifically instructs you to do so. The safest action depends on how late the dose is, the dosing schedule and the dog’s clinical stability.

Use the missed-dose guide for general principles, and contact the clinic when the dog has unstable Cushing’s disease or has recently had a dose adjustment.

What if an extra dose is given?

An accidental extra dose can increase the risk of excessive adrenal suppression. Contact the veterinarian or an animal poison service with the capsule strength, number of capsules involved, the dog’s weight, normal schedule and time of the possible error.

Do not wait for collapse if the dog begins vomiting, has diarrhea, refuses food or becomes weak. Do not give another dose until the veterinary team has advised what to do.

Trilostane and heart medicines

FDA owner information warns that Vetoryl should not be used with certain medicines used to treat heart disease. The interaction concern is particularly relevant to drugs that affect the renin-angiotensin-aldosterone system or potassium balance. A dog with Cushing’s may also be older and have heart disease, so medication reconciliation is essential.

Give the veterinarian a complete list that includes enalapril, benazepril, spironolactone, potassium supplements, diuretics and any other cardiovascular medicine. Do not assume two specialists already have each other’s current list.

Kidney and liver disease

FDA labeling identifies kidney or liver disease as important reasons for caution and may contraindicate Vetoryl in affected dogs. Those organs influence how a sick dog tolerates treatment and how changes in hydration or electrolytes are handled.

Baseline chemistry before treatment and repeat testing afterward help distinguish pre-existing disease from changes that emerge during therapy. If kidney or liver values change, the answer may be a dose adjustment, temporary interruption or a reassessment of whether trilostane remains appropriate.

Pregnancy, breeding and handling

Trilostane interferes with steroid-hormone synthesis and should not be used casually in pregnant, nursing or breeding animals. FDA labeling includes reproductive cautions, and human exposure should also be minimized according to the product instructions.

Keep capsules in the original container and wash hands after handling. If a capsule is damaged, follow the product’s handling instructions rather than transferring powder to food by hand.

Why water intake is worth tracking

Excessive drinking is one of the most recognizable signs of canine Cushing’s. Measuring daily water use over several days can give the veterinarian a more objective view than “he seems less thirsty.” A downward trend can support clinical improvement.

Water should not be restricted to make the symptom look better. A treated dog must have normal access to fresh water, and a sudden dramatic reduction in drinking accompanied by illness should be reported.

Appetite can be a useful treatment clue

Many dogs with uncontrolled Cushing’s are unusually hungry. A return toward normal appetite may be welcome. Complete loss of appetite is different. Merck notes that appetite and water consumption can help clinicians judge response, but owners need to distinguish normalization from illness.

Write down whether the dog finishes normal meals rather than judging from begging behavior alone. Appetite changes are especially important around a dose increase.

Skin, coat and muscle changes take time

Thin skin, hair loss, recurrent infection and muscle wasting develop gradually and recover gradually. Owners should not increase trilostane because the coat has not regrown after a few weeks. Hormonal control may improve before visible dermatologic recovery.

Secondary bacterial or yeast infections may still need direct treatment. Calcinosis cutis can be particularly slow and may influence whether another Cushing’s treatment strategy is considered.

Trilostane does not treat every cause of panting

Panting may improve as cortisol excess is controlled, but heart disease, pain, heat, anxiety, respiratory disease and medications such as corticosteroids can also cause panting. A new increase should not automatically trigger a trilostane dose change.

Look at the whole dog: appetite, water intake, breathing effort, activity and other medications. If breathing is labored rather than simply increased panting, seek veterinary care.

Why repeat endocrine testing can be confusing

There is no perfect single laboratory number that replaces clinical assessment. Veterinarians may use ACTH stimulation testing, pre-trilostane cortisol, post-trilostane cortisol or combinations of clinical signs and laboratory results depending on current guidance and the individual patient.

Testing timing matters. A cortisol result collected at the wrong point relative to a dose can be difficult to interpret. Follow the clinic’s instructions closely about whether to feed and medicate before the appointment.

Stress doses and adrenal crisis concerns

A dog whose adrenal function has been overly suppressed may not produce enough corticosteroid during illness or stress. Severe hypoadrenocorticism can involve dehydration, low blood pressure, electrolyte changes and collapse.

If a dog on trilostane becomes acutely ill, tell the emergency veterinarian that it takes an adrenal suppressant and when the last dose was given. That information can change diagnostic and treatment priorities.

Can trilostane cure Cushing’s disease?

Medical therapy usually controls hormone production rather than curing the underlying tumor. Dogs with pituitary-dependent disease generally need ongoing treatment and monitoring. Some adrenal tumors can be surgically removed in suitable patients, potentially changing the need for long-term medication.

The appropriate goal may be symptom control and quality of life rather than making every endocrine test look completely normal.

What if symptoms return after months of good control?

Cushing’s disease and the dog’s response to trilostane can change over time. Increased thirst, hunger, panting or skin disease after a stable period may mean the disease is less well controlled, but diabetes, kidney disease, infection or another illness can produce similar signs.

Do not increase the capsule amount independently. The clinic may repeat examination and testing before changing the prescription.

Trilostane and diabetes mellitus

Cortisol excess can contribute to insulin resistance, so Cushing’s disease and diabetes can coexist. When cortisol control improves, insulin requirements may change. That makes home glucose monitoring and communication with the veterinary team especially important in a diabetic dog starting trilostane.

Never change insulin solely because thirst improves. Blood glucose trends and clinical signs should guide diabetes adjustments.

Dental work, surgery and other stressful events

Tell the veterinary team that the dog takes trilostane before anesthesia, surgery or a major procedure. The clinician may want recent electrolytes, adrenal assessment or specific instructions about the dose on the day of the procedure.

Do not apply a universal rule about giving or withholding trilostane. The dog’s adrenal reserve, illness severity and procedure all matter.

Keeping a practical home record

A useful Cushing’s log can be simple. Record appetite, water intake if your veterinarian recommends measuring it, urination changes, panting, energy, vomiting, diarrhea and the dates of dose changes or blood tests. Photographs can help track skin and coat recovery over months.

Bring the record to follow-up appointments. A clear timeline often tells the clinician more than trying to remember how thirsty the dog was six weeks earlier.

Questions to ask at each recheck

Ask whether the current goal is based mainly on clinical signs, ACTH stimulation testing or another cortisol measurement. Confirm when the next blood test is due and which signs should make you stop the medicine and call.

Also ask how to handle the medication during vomiting, diarrhea, surgery or another acute illness. Written sick-day instructions can prevent uncertainty later.

Reliable sources

The FDA’s guide to treating Cushing’s disease in dogs explains Vetoryl approval, monitoring and important adverse effects. The Merck Veterinary Manual Cushing disease chapter describes trilostane’s role, adrenal suppression risk and monitoring approaches.

Product-specific instructions should come from the current veterinary label and the veterinarian managing the dog.

Why consistency between rechecks matters

Try to keep meal timing, capsule timing and the way you record symptoms reasonably consistent between visits. Large day-to-day changes in administration can make both clinical response and cortisol testing harder to interpret. If the routine must change because of work, travel or feeding problems, tell the veterinary team rather than quietly changing how the medicine is given.

Consistency does not mean ignoring illness. Vomiting, diarrhea, appetite loss, weakness or collapse are reasons to stop treating the day as routine and contact the veterinarian promptly.

Bottom line

Trilostane is the main medical treatment for many dogs with Cushing’s disease and can substantially improve excessive thirst, urination, appetite, panting and other cortisol-related problems. Its effectiveness depends on finding a balance: enough adrenal suppression to control disease without creating hypoadrenocorticism.

Give it with food as directed, keep scheduled monitoring, do not make dose changes from symptoms alone, and stop and contact the veterinary team promptly if the dog becomes ill with appetite loss, vomiting, diarrhea, weakness or collapse.

DogMedsHub provides source-backed canine medication guidance only and does not diagnose, prescribe or replace veterinary care.